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Abstract
Background: Usability flaws in medication alerting systems may have a negative impact on clinical use and patient
safety. In order to prevent the release of alerting systems that contain such flaws, it is necessary to provide designers
and evaluators with evidence-based usability design principles. The objective of the present study was to develop a
comprehensive, structured list of evidence-based usability design principles for medication alerting systems.
Methods: Nine sets of design principles for medication alerting systems were analyzed, summarized, and
structured. We then matched the summarized principles with a list of usability flaws in order to determine
the level of underlying evidence.
Results: Fifty-eight principles were summarized from the literature and two additional principles were defined,
so that each flaw was matched with a principle. We organized the 60 summarized usability design principles
into 6 meta-principles, 38 principles, and 16 sub-principles. Only 15 principles were not matched with a usability flaw.
The 6 meta-principles respectively covered the improvement of the signal-to-noise ratio, the support for collaborative
working, the fit with a clinician’s workflow, the data display, the transparency of the alerting system, and the actionable
tools to be provided within an alert.
Conclusions: It is possible to develop an evidence-based, structured, comprehensive list of usability design principles
that are specific to medication alerting systems and are illustrated by the corresponding usability flaws. This list represents
an improvement over the current literature. Each principle is now associated with the best available evidence of its
violation. This knowledge may help to improve the usability of medication alerting systems and, ultimately, decrease the
harmful consequences of the systems’ usability flaws.
Keywords: Human engineering, Usability, Alerting system, Decision support, Design
Background
Medication alerting systems “provide real-time notifica-
tion of errors, potential hazards or omissions” related to
the prescription of medications, and thus help clinicians
to make informed decisions (nota bene: in the present
report, a “clinician” is defined as any healthcare profes-
sional who interacts with the patient; the term therefore
encompasses physicians, nurses and pharmacists) [1].
These promising technologies can change prescribers’
behavior by helping them avoid errors [2] and, ulti-
mately, can improve the quality of the medication
management process [3]. Nonetheless, the design and
the implementation of these tools may introduce nega-
tive, unforeseen side effects: poor integration into the
clinical workflow [4], acceptance issues, and decreased
safety and quality of care, for example [5]. Some of these
issues are related to the usability of the alerting systems
[6]; they are caused by defects in the design of the sys-
tem, i.e. usability flaws. For instance, alerts may be
poorly integrated into the workflow and may appear too
late in the decision-making process – rendering the
alerting system useless [7, 8]. In other cases, the content
of the alert is either incomplete or not visible enough to
adequately support a clinician’s decision making – lead-
ing to incorrect clinical decisions [9]. This lack of infor-
mation also increases the clinician’s cognitive load [10].
Alerts may be poorly written or explained - causing
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misunderstandings or at least creating difficulties in un-
derstanding them. These cognitive issues may also lead
to incorrect clinical decisions [11–13]. In summary,
these and other usability flaws in the alerting system
may have severe consequences, such as rejection of the
alerting system, and incorrect clinical decisions. There-
fore, the usability of an alerting system warrants special
scrutiny, with a view to avoiding usability-induced use
errors at least.
To prevent the usability of alerting systems from intro-
ducing errors, usability activities (e.g. design specifications
and prototype evaluation) must be undertaken during the
technology development process [14]. The implementa-
tion of those activities requires a sound knowledge of
good usability design principles (also known as usability
heuristics and usability criteria). Violation of those
principles may generate usability flaws in the technology.
With a view to helping companies to avoid the release of
medication alerting systems that contain unintentional
violations of these principles, it is necessary to provide
designers and evaluators with easy access to relevant, illus-
trated usability design principles and to convince them of
the value of applying these principles to design decisions.
In summary, designers and evaluators of medication alert-
ing systems need to access evidence-based usability design
principles, i.e. usability design principles that have proven
their value in practice [15]. As far as we know, the present
study is the first to have provided evidence-based usability
design principles for medication alerting systems.
Putting together a body of evidence relies on the accu-
mulation of results that demonstrate the positive value
of applying design principles. Unfortunately, publications
in the field of usability evaluation tend to report only
negative results, i.e. instances of usability flaws. This
reporting bias prevents the collection of evidence to
show that applying principles is beneficial. Hence,
although it is not yet possible to demonstrate the posi-
tive value of applying usability design principles, it is still
possible to demonstrate the negative consequences of
violating them.
In previous research, we started to develop a usability
knowledge framework (Fig. 1; [16]). We have used this
framework to gather evidence-based usability design
principles for medication alerting systems. In a first step,
we performed a systematic review of the literature to
identify the usability flaws in medication alerting systems
used in hospital and/or primary care (active or passive
alerts, and use as a standalone system or integrated into
a larger information system) [17]. In a second step, we
searched for the consequences of these flaws on users
(usage problems; e.g. alert fatigue and missed informa-
tion) and on the work system (negative outcomes; e.g. a
decrease in effectiveness, and patient safety issues), and
linked them to their cause [6].
The third step involves identifying, summarizing, and
organizing published design principles so as to avoid
“reinventing” principles as far as possible. The fourth
step (in line with previous work by Nielsen [18]) seeks
to match usability flaws to the usability design principles
that could fix them and thus obtain empirical illustra-
tions of the principles’ violation. The present study tack-
led the third and fourth steps. The results will help to
establishing evidence in support of these principles.
The present study had two objectives. Firstly, it sought
to identify and organize literature reports of usability de-
sign principles for medication alerting systems in hos-
pital or primary care settings into a comprehensive,
structured list of design principles. Secondly, the study
sought to match this list with the set of usability flaws
identified in the systematic review [17], in order to as-
sess the fit between known usability flaws and known
existing design principles and thus illustrate violations of
these principles.
Methods
A two-step methodology was applied.
Fig. 1 Top: a graphical representation of the evidence-based usability knowledge framework. The numbering refers to the four steps, as
described in the text. The question marks refer to the steps tackled in the present study. Bottom: an instance of the cause-consequence chain
linking a usability flaw, a usage problem and a negative outcome (adapted from [27])
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Gathering and structuring usability design principles
We searched peer-reviewed journals and conference pa-
pers for published consensus sets of usability design
principles for medication alerting systems (i.e. principles
that experts in the field had agreed on). The “grey” litera-
ture was excluded because the quality of the information
may vary. Hence, we searched PubMed, Scopus, and
Ergonomics Abstracts databases for articles addressing
both “medication alerting systems” and “usability” topics.
With this goal in mind, we used the screening and eligibil-
ity assessment steps from our previous systematic review
[17] to identify papers purposefully providing at least one
usability design principle dedicated to medication alerting
systems. We excluded system-specific papers providing
recommendations on improving usability because these
principles are not applicable to a broad range of systems.
This task was updated on March 30th 2016. The literature
search was intended to provide an overview of published
sets of usability design principles for medication alerting
systems, rather than being systematic and reproducible.
The database search was completed by examining the in-
vestigators’ personal libraries and by screening the refer-
ences of the selected publications. Two investigators
(MCBZ and RM) decided on the final list of publications
by consensus.
Once relevant publications had been identified, one in-
vestigator (RM) extracted all items referring to usability
design principles from each publication. Next, the inves-
tigator grouped together principles with similar purposes
and organized them hierarchically. A second investigator
(MCBZ) independently crosschecked the hierarchical
organization of the principles. Disagreements were
solved by discussion until a consensus was reached.
Lastly, the two investigators summarized the principles
that had been grouped together.
Matching usability design principles to known usability
flaws
One investigator (RM) checked the list of usability flaws
published in the on-line appendices of Marcilly et al. [17]
against the structured list of usability design principles. A
second investigator (MCBZ) crosschecked the results. Dis-
agreements were discussed until a consensus was reached.
The items referring to usability flaws were either descrip-
tions of the technology’s defects observed during field
studies or usability tests, answers to interviews/question-
naires, or users’ positive or negative comments about the
characteristics of the technology collected during their
interaction with the system. A usability flaw was matched
to a given usability design principle if it was an instance of
a violation of the said principle. Reciprocally, a usability
design principle matched a usability flaw if the application
of the principle stopped the flaw from occurring. If a flaw
did not match any of the usability design principles, then
we considered the possible extension (broadening) of an
existing principle to other contexts so that it covered a
wider range of flaws. If no principles could be extended to
cover the flaw, we defined a new principle.
The matching process was intended to be as unequivocal
as possible, i.e. one flaw matched one principle. However, if
a given usability flaw violated several principles (e.g. at
different levels of granularity), we matched that flaw to the
most significantly violated principles (based on our experi-
ence). It should be noted that a given principle could be
matched with several instances of the same flaw.
Figure 2 illustrates the matching process. Both investi-
gators performed the descriptive analysis of the matches.
Results
Gathering and structuring usability design principles
We identified 9 publications on design principles dedi-
cated to medication alerting systems (Table 1).
Figure 3 describes the sets of publications analyzed.
One publication (Zachariah et al. [22]) was included in
both sets; although this publication was an extension of
another set of design principles described by Phansalkar
et al. [20], it contained a few usability design principles
not found in the original publication [20]. The publica-
tion also gave a list of usability flaws detected using
heuristics. Despite the potential for self-matching bias,
this publication was included because our objective was
to obtain the most comprehensive possible list of design
principles. Moreover, it was found that virtually all first
authors of the set of usability design principles were
co-authors of one or more studies included in the review
of usability flaws (e.g.[1, 4, 20, 23]).
A total of 345 items referring to usability design princi-
ples were extracted from the 9 publications (see Add-
itional file 1: Appendix 1) and then organized. The level of
agreement between the two investigators regarding the
organization of the items was very high, with full agree-
ment for 92.6% of the combinations, discussion needed
for 6%, and disagreement for 1.3%. After a consensus
meeting, the items were summarized into 58 principles.
No significant inconsistencies between principles from dif-
ferent publications were noticed. The summarized princi-
ples displayed different granularity levels, and some were
more tangible and precise than others; they could there-
fore be organized hierarchically into 6 meta-principles, 36
principles, and 16 sub-principles (Fig. 4, Table 2).
Overall, the 9 publications contributed to different ex-
tents to the set of summarized principles: the contribu-
tions ranged from 12% [22] to 69% [24] (see Additional
file 2: Appendix 2).
The level of support for each of the summarized prin-
ciples (in terms of number of publications in which they
were found) varied: one summarized principle was sup-
ported by all 9 papers (#49 “Include actionable tools
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within the alert”), “Suggest, do not impose” (#42) was
supported by 8 publications, and 6 principles were found
in 1 publication. When considering the overall
meta-principles and their components (i.e. related prin-
ciples and sub-principles), the level of support ranged
from 5 publications for meta-principle E (“Make the sys-
tem transparent for the user”) to 9 publications for
meta-principle D (“Display relevant data within the
alert”) and meta-principle F (“Include actionable tools
within the alert”).
Matching usability design principles with known usability
flaws
The two investigators agreed well on the matching
between usability flaws and usability design principles,
with full agreement for 54.6% of matches, partial
agreement for 31% (agreement on the main corre-
sponding principle but a need to match the flaw with
a second principle), discussion needed for 13.4%, and
disagreement for 1%. Of the 58 principles, 34 directly
matched at least one instance of a usability flaw, nine
were broadened to cover a flaw, and 15 were not
matched at all (see Additional file 3: Appendix 3).
Two new principles were defined so that all flaws
matched a principle (#46, provide “a description of
the characteristics of the tools included in the alert”
to users, and #57, include a “send the alert into the
clinical note template” function in the alert).
After the addition of the 2 new principles, the final set
comprised 60 summarized usability design principles: 6
meta-principles, 38 principles, and 16 sub-principles.
The 6 meta-principles were as follows:
Fig. 2 Illustration of the matching process, using meta-principle E (#44) and one of its sub-principles (#48). The usability design principles found
in the literature were summarized and organized hierarchically (left). The usability flaws identified in the systematic review were collated by topic
(right). Next, the correspondence between a given type of flaw and a given summarized principle was established based on the principle’s ability
(if applied) to fix the usability flaw. This correspondence is represented by a double arrow. When a usability flaw could not be fixed by any of the
design principles in the literature, we either extended an existing principle or created a new one (single arrow). The illustration presents an
extension of principle #48 (in italics)
Table 1 Main characteristics of the publications on usability design principles
First author Year Focus Method used to provide the principles
[2] Bates DW 2003 Design, implementation, monitoring Lessons learned
[19] Kuperman GJ 2007 Design, implementation Expert consensus
[4] Sittig DF 2008 Design, implementation, research Lessons learned / expert consensus
[20] Phansalkar S 2010 Usability Targeted review
[21] Pelayo S 2011 Usability Targeted review & analysis of cognitive and
collaborative tasks
[22] Zachariah M 2011 Development of a usability evaluation
instrument
Phansalkar et al.s’ review and feedback from
a preliminary evaluation
[1] Horsky J 2012 Usability Targeted review
[23] Horsky J 2013 Usability Targeted review
[24] Payne T 2015 Usability Expert consensus
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A. Improve the system’s signal-to-noise ratio, in
order to decrease the frequency of over-alerting. In
addition to the drugs ordered, the alert strategy
should take into account parameters such as the
patient’s clinical context or the clinician’s specialty.
Moreover, the system must provide tools to
customize the knowledge implemented within it
and to monitor alert overrides.
B. Support collaborative work, advocate a team
approach, and make the system a team player.
The alerting system must encourage collaboration
between the healthcare professional managing
medications (e.g. physicians, pharmacists and
nurses). Overall, alerts must deliver the same
information to all clinicians, even if additional
supplementary data can be presented as a function
of the healthcare professional’s role. The alerting
system must help clinicians to understand how
other healthcare professionals have already
managed the alert.
C. Fit with clinicians’ workflow and their mental
model. The alerting system must comply with
clinicians’ needs and tasks. Alerts must be
presented at the right moment in the decision-
making process. Only the most severe alerts must
interrupt the users; other alerts must be displayed
more discreetly. Alerts must be concise, under-
standable and consistently structured so that users
can easily find the relevant data. Once the alert has
been satisfied, the clinicians must be able to resume
their tasks easily.
D. Display relevant data within the alert. The
system must provide clinicians with the
information needed to make informed decisions.
This includes the cause of the unsafe event (the
medications involved), the description of the
unsafe event, the severity/priority of the event,
the mechanism of the interaction, the patient’s
clinical context, and evidence supporting the
alert. Lastly, the system must suggest – but not
impose – a means of remedying or monitoring
the unsafe event.
E. Make the system transparent for the user. The
alerting system must help clinicians to understand
what the system can and cannot do and how it
works, in order to prevent erroneous interpretation
of its behavior. The user must have access to (i) the
types of data that are checked, (ii) the formulas and
rules applied, (iii) the list of the unsafe events that
are targeted, and (iv) a description of the alerts’
levels of severity.
F. Include actionable tools within the alert. The
alert must provide several tools that help clinicians
to easily and quickly translate their alert-informed
clinical decision into actions: for example, buttons
to modify/cancel/discontinue an order or override
the alert, to order actions for monitoring an event,
and to provide patient education. Other tools are
recommended for managing the alert: pulling up
the alert at a later time, sending the alert into a
clinical note, removing the alert for a patient, and
gaining access to the patient’s medical records.
The final list of summarized usability design principles
is given in Fig. 4. Table 2 provides a detailed version of
the principles and corresponding flaws.
Discussion
Answers to study questions
The present study sought primarily to provide a specific,
comprehensive, structured list of usability design princi-
ples for the medication alerting systems implemented in
hospital or primary care settings. The secondary object-
ive was to pair this list with the set of documented us-
ability flaws, assess the match between the usability
flaws that are known and the existing design principles,
obtain illustrations of the existing violations of the prin-
ciples, and present evidence that not applying usability
design principles may be detrimental.
A total of 60 specific usability design principles for
medication alerting systems were identified and
organized hierarchically around 6 meta-principles: (A)
improve the signal-to-noise ratio, (B) support collabora-
tive work, (C) fit the clinicians’ workflow and their
mental model, (D) display relevant data within the
alert, (E) make the system transparent for the user,
and (F) include actionable tools within the alert. The
Fig. 3 Sets of papers analyzed. Left: the set of papers analyzed to
establish a structured list of usability design principles for
medication alerting systems. Right: the set of papers analyzed to
establish the list of usability flaws in medication alerting systems [17]
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9 analyzed publications contributed to this list to dif-
ferent extents; we consider that the collation of sev-
eral sets of usability design principles found in the
literature expands the variety of topics represented in
each individual set.
The match between the summarized usability design
principles and the list of documented usability flaws was
quite good: 34 principles were directly matched, and the
context of application was extended for 9 principles.
Nonetheless, 15 principles did not match any of the doc-
umented usability flaws. In view of the hierarchical
organization of the principles, some principles are also
not matched because their meta-principle or one or
more of their sub-principles are matched - thus artifi-
cially reducing the quality of the match. We also identi-
fied limited gaps in the principles found in the literature;
two new principles had to be created.
From a qualitative point of view, a few instances of
usability flaws appear to contradict the corresponding
usability design principles. For instance, some princi-
ples recommend including non-prescribers (e.g. phar-
macists and nurses) in the alert management process,
in order to promote collaboration between healthcare
professionals (e.g. #20). However, it has been reported
that nurses are annoyed by medication alerts that
interrupt their work [26]. The balance between pro-
moting collaboration between healthcare professionals
and not disrupting non-prescribers’ tasks is delicate.
Overall, instances of usability flaws must be used so
that the corresponding design principles are not taken
too literally.
Study strengths
The results of the present study represent an improve-
ment with respect to the current literature. We did not
change the principles extracted from the literature. By
combining and summarizing the extracted principles,
they are now clearly identified, listed, and organized
hierarchically into a comprehensive, consistent, and
structured hierarchy. Furthermore, the process of
matching the principles to the usability flaws allows one
to identifying evidence to show that not applying these
principles has negative consequences. Each principle is
now associated with the best available evidence of its
violation. As far as we know, the present study is the
first to have drawn up this type of list.
In addition to providing evidence, the matching
process also provided concrete illustrations of violations
of usability design principles. The illustrations may help
people designing and evaluating alerting systems to
identify the “usability mistakes” that should not be made
or to catch these mistakes during the evaluation phases.
In fact, the illustrations provide a clearer understanding
of the design principles to be applied.
Study limitations
The retrieval of the usability design principles might
have biased the representativeness of the principles
and the flaws. We considered only publications
reporting general sets of design principles, rather than
evaluations giving system-specific usability recommen-
dations. Grey literature was excluded. Moreover, most
of the analysis was performed by one investigator,
with a second investigator independently crosscheck-
ing the results. Together, these biases might have
caused us to miss a few relevant principles. Conse-
quently, the principles that we extended or created in
the present study may have already been described in
other publications (e.g. as system-specific recommen-
dations on usability). Likewise, some usability flaws
might have been missed during the systematic review
[17] due to publication and reporting biases: it might
have been possible to match principles not matched
in the present study with usability flaws documented
outside our review [17]. Despite these limitations, the
match between the usability design principles and the
usability flaws was quite good and ensured that the
principles and flaws retrieved were representative.
This good level of matching might be due (at least in
part) to the inclusion of Zachariah’s publication [22]
and reports written by closely linked authors in both
sets of publications (i.e. the set used to establish the
list of principles and the set used to establish the list
of flaws, e.g. [4, 20, 23]). In the present study, the
risk of self-matching bias was considered to be ac-
ceptable because our objective was to obtain the most
comprehensive possible list of design principles and
corresponding flaws. On the contrary, not including a
publication in one set because its authors had also
worked on a publication included in the other set
could have led us to ignore relevant usability design
principles and/or usability flaws.
The frequency of appearance of the design principles
was analyzed in order to establish the level of support
for the design principles (i.e. the number of publications
they were found in). However, we do not interpret this
number as an indicator of which principles should be
prioritized. Firstly, reporting and publishing biases and
differences in the focus of the publications analyzed may
have biased the frequency of appearance. Even without
these biases, prioritizing the principles would imply that
we are able to predict the severity of the consequences
of the related usability flaws. However, the severity de-
pends on many other factors, such as the system’s other
features and other flaws, and the context of use. This is
one reason why most sets of design principles - whether
developed for interactive systems (e.g. Nielsen’s [43] and
Scapin’s [44] sets) or for a specific type of technology
(e.g. the ones included in our analysis) - do not prioritize
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principles. Design principles can be prioritized by a per-
son who is aware of the alerting system’s characteristics
and context of use.
In the present study, we addressed the evidence in
favor of usability design principles by examining the
violation of these principles. Evidence to suggest that
applying design principles is beneficial has not yet
been considered, due to reporting bias in the litera-
ture. Even though our present evidence is not based
on instances of successful design, it may be convin-
cing enough to persuade designers to apply usability
design principles. Once researchers have begun to
report on the positive usability characteristics of
medication alerting system, the present analysis will
have to be updated.
The significance of the present results for a user
interacting with a medication alerting system
Usability design principles are related to various compo-
nents of the alerting system: the triggering model, the
knowledge implemented, the cognitive model implemented
in the system, the information displayed, and the tools pro-
posed within the alert. Applying these usability design prin-
ciples might improve the clinician-alerting system
interaction and the collaboration between clinicians. Ac-
cording to Norman’s “seven stages of action” model [45],
the user’s interaction with a system encompasses two
stages: the action stage translates a goal into an action
sequence, and the evaluation stage compares the changes
perceived in the world with the initial goal of the action
(see Fig. 5). A clinician interacts with an alerting system in
order to check the appropriateness of the prescriptions
(step 1). Two “action and evaluation loops” may then be
described. The main loop is “display/read” the alert. The
second “acknowledgement” loop depends on the alerting
system model; in some models, acknowledgment is not
required.
For the “display/read” loop (loop a, Fig. 5, left), improving
the overall usability of the alerting system by applying the
whole set of design principles may facilitate the interaction
and increase the clinician’s intention to use the alerting sys-
tem (step 2). More specifically, the whole “improving the
signal-to-noise ratio” meta-principle may help to improve
the relevance of the alerts, decrease alert fatigue, and thus
increase the clinician’s will to use the alerting system. In
step 3, principles such as “signal the availability of informa-
tion to all users” (#18) and “display the alert at the appro-
priate time” (#24) could make it easier to notice and
retrieve alerts. In step 4, applying the “fit the clinician’s
workflow” meta-principle may help the clinician to display
the alerts. Once alerts are displayed, clinicians have to read
and interpret them (in steps 5 and 6). Applying the “use a
consistent structured alert template”, “display relevant
data”, and “make the system transparent” principles (#31,
#36, and #44, respectively) may make the alerts more
readable and help the clinicians to interpret them. Lastly,
“extend[ing] the sources of information used in the trigger-
ing model” (#4) may make it easier for clinicians to assess
the alerts’ relevance (step 7).
Once alerts are interpreted, physicians may have to
acknowledge them (loop b, Fig. 5, right). Applying the
“suggest - do not impose” principle (#42) may increase
the probability with which a clinician acknowledges the
alert and perform corrective actions (step 2). Next,
“includ[ing] actionable tools within the alerts” (#49) may
make it easier and quicker to specify and execute
corrective actions (e.g. modify the order; step 3). If a
physician overrides an alert and enters the reason why,
“display[ing] override reason” (#19) might help other
clinicians to interpret the alert’s acknowledgement status
(step 6) and decide whether or not the alert has been
properly assessed.
In summary, applying this set of usability design princi-
ples might improve both the action and evaluation stages
of a user’s interaction with the alerting system - mainly in
the “display/read” loop but also in the “acknowledgement”
loop. Some principles go beyond Norman’s model, which
relates to an individual’s interaction with the alerting
system and not interactions between clinicians or the
clinicians’ workflow. Adhering to the “fit the clinicians’
workflow” meta-principle might decrease the risk of rejec-
tion. Moreover, if the “support collaborative work”
meta-principle were to be applied, the alerting system
could truly help clinicians to gain the same mental repre-
sentation of the prescription being checked; this would
help them to coordinate their actions and improve patient
safety.
Generalizability of the study
The list of usability flaws used in the matching process
might increase over time, depending on whether new
publications report usability flaws. Moreover, technology
evolves rapidly, and the related principles might change
accordingly. For instance, the principles presented here
are formulated for medication alerting systems imple-
mented on laptop and/or desktop computers. However,
as mobile health technologies are refined and expanded,
alerting systems will be progressively installed on mobile
devices. This might modify the applicability of the us-
ability design principles listed here. It will therefore be
essential to update this work regularly and take account
of the latest trends and developments. However, the
maintenance of this knowledge may be time-consuming,
and represents a challenge for human factors specialists
in the field of medical informatics. Manufacturers should
be associated with this process.
Some design principles insist on the need for promot-
ing collaboration between clinicians (#16) but ignore the
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key person in the medication management process - the
patient. Only principle #54 mentions the patient (being
able to “provide patient education”). However, as for
other information technologies, the implementation of
an alerting system changes the nature of the
patient-clinician interaction [46]. It is important to en-
sure that poor usability has not damaged the
patient-clinician interaction. On the contrary, increased
usability should underpin patient-clinician discussion,
empower the patient [47], and ensure that care remains
patient-centered. The current literature on the usability
of medication alerting systems does not consider the pa-
tient as a stakeholder in medication management. Future
research on the usability of medication alerting system
should integrate patients as stakeholders in medication
management, so as to adapt or extend usability design
principles to their specific features.
Although the structured design principles target
only medication alerting systems implemented in
hospital or primary care settings, some principles may
be applied to other kinds of alerting systems. For in-
stance, part of the “fit the clinicians’ workflow”
meta-principle could also be applied to laboratory re-
sult alerting systems. Nonetheless, the evidence that
underpins the principles presented here is valid for
medication alerting systems only.
In addition to the results, the method used to build
this set of evidence-based usability design principles
could also be applied to evidence-based usability design
principles for other kinds of technology. However, this
method is very time-consuming, and requires in-depth
knowledge of the usability of the technology in question
if the data are to be analyzed correctly.
Turning the results into a usable, practical tool for
designers and evaluators
The present set of evidence-based usability design princi-
ples for medication alerting systems must be made access-
ible to and usable by designers and evaluators. At present,
the principles are presented as a printable table (Table 2)
that might not be ideal for optimal use. We intend to use
the table to develop tools that present the evidence-based
knowledge in a way that suits the needs of the various sys-
tem designers and evaluators (usability experts, computer
scientists, etc.) in various contexts of use (design,
evaluation, procurement processes, etc.). With that aim in
mind, we have started to identify the needs of medication
alerting system designers and evaluators [48]. Accordingly,
we developed (i) a checklist that measure the appropriate
use of evidence-based principles in the design of medica-
tion alerting systems, and (ii) a set of interactive design
instructions illustrated by visual representations of good
and bad usability practices, in order to help designers make
informed design decisions.
This list of usability design principles should help de-
signers to make evidence-based usability design decisions.
Nonetheless, and even though we believe that the list is
helpful, it is not intended to be used as a stand-alone sys-
tem or to replace the requirement for expertise in usability
and design. Firstly, the present list does not include gen-
eral design principles for unspecified interactive systems;
it must therefore be used in combination with sets of
general usability design principles for interactive systems
(e.g. [43, 44]). Secondly, several principles require insights
into the users’ cognitive tasks and their decision-making
processes in order to adjust (for instance) an alert’s format
and the moment at which it appears (e.g. #24). Hence,
work system and cognitive work analyses [49] must be
performed so the principles are applied in an optimal way.
Thirdly, principles moderate each other; they must not be
applied alone or in an unquestioning manner. Human
factors specialists and designers must use their expertise
to determine which principles must be applied and how
they must be applied, given the characteristics of the aler-
ting system and the setting in which it is implemented in
(hospital vs. primary care, for example). In summary, this
structured list of usability design principles must be used
as a support for expertise and not as a substitute for it.
Applying some of the principles listed here may
present specific technical and organizational challenges
when seeking to tailor alerts. For instance, the “prioritize
the alerts according to patient’s clinical context and the
severity of the unsafe event” (#8) principle requires
access to valid data on the patient’s clinical context, stay,
and treatment. However, these data are often not stan-
dardized or structured enough to be used in the alerting
system’s set of rules [50]. Further research is needed to
overcome these challenges.
Ultimately, presenting designers and evaluators with
evidence-based knowledge may help to decrease the
occurrence of unforeseen and potentially harmful
usability-induced use errors. Nonetheless, one must be
aware that improving the usability of an existing system or
ensuring that the usability of a system under development
is optimal is no guarantee of success. Other issues arising
during the development of a medication alerting system
(e.g. an error-ridden knowledge base, a poor implementa-
tion process, unsuitable settings, etc.) can ruin even opti-
mal levels of usability. Even though it is necessary to
consider usability during the design, development, and
evaluation of medication alerting systems, one must never
neglect the relevant technical, social, and managerial fac-
tors that also contribute to the system’s success or failure.
Conclusions
In the present study, we developed an evidence-based,
structured, specific, comprehensive list of usability design
principles for medication alerting systems, and then
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illustrated them with the corresponding usability flaws. This
list should help designers and usability experts to gain a
better understanding of usability design principles. We ex-
pect that the list can be used during the design and evalu-
ation processes of medication alerting systems, in order to
prevent usability issues that could have a counterproductive
impact on clinicians (e.g. alert fatigue) and potentially
harmful outcomes for patients (e.g. errors in medication
dosing). Although operational barriers may complicate the
deployment and maintenance of the evidence-based usabil-
ity design principles presented in the present study, our re-
sults show that the approach is feasible. Indeed, our
approach could be transferred to other health information
technologies for the generation of specific lists of
evidence-based usability design principles. In this way, de-
signers and evaluators could be provided with tools to help
them avoid usability design issues in health information
technology and thus decrease the likelihood of unforeseen
and potentially harmful usability-induced use errors.
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